Association between polymorphisms in the DNA repair genes, XRCC1, APE1, and XPD and acute side effects of radiotherapy in breast cancer patients

被引:150
作者
Chang-Claude, J
Popanda, O
Tan, XL
Kropp, S
Helmbold, I
von Fournier, D
Haase, W
Sautter-Bihl, ML
Wenz, F
Schmezer, P
Ambrosone, CB
机构
[1] German Canc Res Ctr, Div Clin Epidemiol, D-69120 Heidelberg, Germany
[2] German Canc Res Ctr, Dept Toxicol & Canc Risks Factors, D-69120 Heidelberg, Germany
[3] Univ Heidelberg Hosp, Dept Gynecol Radiol, Heidelberg, Germany
[4] St Vincents Kliniken Karlsruhe, Clin Radiotherapy & Radiooncol, Karlsruhe, Germany
[5] Karlsruhe Hosp GmbH, Clin Radiotherapy, Karlsruhe, Germany
[6] Univ Klinikum Mannheim, Dept Radiat Oncol, Mannheim, Germany
[7] Roswell Pk Canc Inst, Dept Epidemiol, Div Canc Prevent & Populat Sci, Buffalo, NY 14263 USA
关键词
D O I
10.1158/1078-0432.CCR-04-2657
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: Several DNA repair gene polymorphisms have been described, which affect DNA repair capacity and modulate cancer susceptibility. We evaluated the association of six polymorphisms in the DNA repair genes: XRCC1 (Arg(194) Trp, Arg(280)His, and Arg(399)GIn), APE1 (Asp(148)Glu), and XPD (Lys(751)Gln and Asp(312)Asn), with the risk of acute skin reactions following radiotherapy. Design: We conducted a prospective study of 446 female patients with breast cancer who received radiotherapy after breast-conserving surgery. Individual genetic polymorphisms were determined using melting point analysis of sequence-specific hybridization probes. The development of acute skin reactions (moist desquamation) associated with DNA repair gene polymorphisms was modeled using Cox proportional hazards, accounting for cumulative biologically effective radiation dose. Results: Overall, the development of acute toxicity, which presented in 77 patients, was not associated with the genetic variants studied, although the hazard ratios (HR) were generally below 1. Risks were however differential by body mass index. Among normal-weight patients only, both carriers of theAPE1 (148)Glu and the XRCC1 (399)Gln alleles had decreased risk of acute skin reactions after radiotherapy (HR, 0.49 and 0.51, respectively). The results for XRCC1 were confirmed by haplotype analysis. When considering joint effects, we observed that compared with homozygote carriers of the wild-type allele in both genes, the risk was most strongly reduced in carriers of both APE1 (148)Glu and XRCC1 (399)GIn alleles with normal weight [HR, 0.19; 95% confidence interval (95% CI), 0.06-0.56] but not in those with overweight (HR, 1.39; 95% CI, 0.56-3.45; P-interaction = 0-009). Conclusion: The XRCC1 (399)Gln or APE1 (148)Glu alleles may be protective against the development of acute side effects after radiotherapy in patients with normal weight.
引用
收藏
页码:4802 / 4809
页数:8
相关论文
共 45 条
[1]  
Angèle S, 2003, CANCER RES, V63, P8717
[2]   STRUCTURE AND FUNCTION OF APURINIC/APYRIMIDINIC ENDONUCLEASES [J].
BARZILAY, G ;
HICKSON, ID .
BIOESSAYS, 1995, 17 (08) :713-719
[3]  
Bentzen, 1994, Semin Radiat Oncol, V4, P68, DOI 10.1016/S1053-4296(05)80034-7
[4]   RELATIONSHIP BETWEEN EARLY AND LATE NORMAL-TISSUE INJURY AFTER POSTMASTECTOMY RADIOTHERAPY [J].
BENTZEN, SM ;
OVERGAARD, M .
RADIOTHERAPY AND ONCOLOGY, 1991, 20 (03) :159-165
[5]   The p53 gene as a modifier of intrinsic radiosensitivity: Implications for radiotherapy [J].
Bristow, RG ;
Benchimol, S ;
Hill, RP .
RADIOTHERAPY AND ONCOLOGY, 1996, 40 (03) :197-223
[6]   FIBROBLAST RADIOSENSITIVITY VERSUS ACUTE AND LATE NORMAL SKIN-RESPONSES IN PATIENTS TREATED FOR BREAST-CANCER [J].
BROCK, WA ;
TUCKER, SL ;
GEARA, FB ;
TURESSON, I ;
WIKE, J ;
NYMAN, J ;
PETERS, LJ .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1995, 32 (05) :1371-1379
[7]   THE RELATIONSHIP BETWEEN CELLULAR RADIATION SENSITIVITY AND TISSUE-RESPONSE MAY PROVIDE THE BASIS FOR INDIVIDUALIZING RADIOTHERAPY SCHEDULES [J].
BURNET, NG ;
NYMAN, J ;
TURESSON, I ;
WURM, R ;
YARNOLD, JR ;
PEACOCK, JH .
RADIOTHERAPY AND ONCOLOGY, 1994, 33 (03) :228-238
[8]  
*CANC THER EV PROG, 1998, COMM TOX CRIT
[9]  
Collett D, 2014, MODELLING SURVIVAL D
[10]   Nucleotide excision repair and human syndromes [J].
de Boer, J ;
Hoeijmakers, JHJ .
CARCINOGENESIS, 2000, 21 (03) :453-460